Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ProteoMics is a specialized biotechnology company and contract research organization (CRO) focused on providing advanced mass spectrometry-based proteomics services. The company offers high-resolution protein identification, quantification, and characterization to support drug discovery and development for pharmaceutical and academic partners. Their expertise spans from simple protein identification to complex post-translational modification analysis and biomarker discovery. By leveraging state-of-the-art mass spectrometry platforms, ProteoMics enables researchers to gain deep insights into the proteome of various biological systems.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ProteoMics.